Re: K-V Pharmaceutical Co. Opiniones
Esta es una de las demandas q los antiguos accionistas tenemos contra KV, pendiente de resolución.
Law360, New York (May 01, 2013, 7:10 PM ET) -- A Missouri federal judge refused Tuesday to dismiss a proposed class action against KV Pharmaceutical Co., ruling that top officials likely knew that company reports failed to disclose U.S. Food and Drug Administration regulatory violations and that investors were harmed by plummeting stock prices once the truth was revealed.